Gritstone bio, Inc.
GRTS · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 16.3% | 69% | -98.1% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,707% | -3,455.1% | -6,524.1% | -25.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -35,950.9% | -76,218.4% | -95,444.8% | -2,267% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -41,045.6% | -82,418.4% | -106,269% | -2,455.8% |
| EPS Diluted | -0.16 | -0.34 | -0.32 | -0.33 |
| % Growth | 52.9% | -6.3% | 3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |